The Prophylactic Effect of Levosimendan in Reducting Acute Kidney Injury Postoperatively in Pediatric Patients Undergoing Corrective Heart Surgery
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
Price : $35 *
At a glance
- Drugs Levosimendan (Primary) ; Milrinone
- Indications Acute kidney injury; Postoperative complications
- Focus Therapeutic Use
- Acronyms MiLe-1
- 25 Apr 2017 Status changed from recruiting to completed.
- 18 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Jan 2017.
- 18 Aug 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.